VBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)

Press/Media: Press / Media

PeriodNov 3 2014 → Nov 13 2014

Media coverage

36

Media coverage

  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletReuters
    CountryUnited Kingdom
    Date11/13/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletVirtual Strategy Magazine
    CountryUnited States
    Date11/13/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletConsumer Electronics Net
    CountryUnited States
    Date11/13/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletTutorial Finder
    CountryUnited States
    Date11/13/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletPharmacy Choice
    CountryUnited States
    Date11/13/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletReuters
    CountryUnited Kingdom
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletCNN Money
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletMorningstar.com
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletTown Hall
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletWall Street Business Network
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletSearchBug
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletFat Pitch Financials
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletFranklin Credit Management Corporation
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletMoneyShow.com
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletIndustrial Info Financials
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletReliance Trust
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletBioSpace
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletMarket Pulse Navigator
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletStreet Sweeper
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletCrawford Financial Planning
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletRCL Advisors
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletCEOWorld Magazine
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletTamar Securities
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outlet4 Traders
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletFinancial Content
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletReview Seeker
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletI Stock Analyst
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletAsk.com
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletCW Atlanta
    CountryGeorgia
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletCBS Detroit
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletWGNT
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletMyrtle Beach Sun News
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletThe CW44 Tampa Bay
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletGood Day Sacramento
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletCW 50 Detroit
    CountryUnited States
    Date11/3/14
    PersonsAndrew Brenner
  • TitleVBL Therapeutics to Present Interim Phase 2 Data From VB-111 in Recurrent Glioblastoma at 19th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
    Media name/outletBizWire Express
    CountryIndia
    Date11/3/14
    PersonsAndrew Brenner